Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2000-01-31
2001-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prenatal Depression and Failure to Breastfeed
NCT01252602
Screening Evaluation for Women With Postpartum Depression
NCT00056901
The Relationship Between Maternal Perinatal Depression and Feeding Behavior Among Primiparas
NCT06231602
Determining Relationships Among Maternity Stress & Sleep
NCT02133963
Postpartum Anemia and Postpartum Depression
NCT00782912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In third trimester of pregnancy when recruited
* Negative for the following drugs detected by a urine drug screen:
* Amphetamines
* Barbiturates
* Benzodiazepines
* Cocaine
* Opiates
* Phencyclidine metabolites (PCP), and tricyclic antidepressants
* Vaginal delivery
* Screened negative for major depressive disorder on the Edinburgh Postnatal Depression Scale (EPDS) at her prenatal enrollment in the study
* Receiving a score of 12 or lower out of a possible 30
Exclusion Criteria
* Positive for any of the following drugs:
* Amphetamines
* Barbiturates
* Benzodiazepines
* Cocaine
* Opiates
* Phencyclidine metabolites (PCP), and tricyclic antidepressants
* Cesarean delivery
* EPDS score over 12 at prenatal screening test
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oklahoma State University Center for Health Sciences
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary H. Watson, PhD
Role: STUDY_DIRECTOR
Philadelphia College of Osteopathic Medicine Georgia Campus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oklahoma State University Center for Health Sciences Houston Park Obstetrics Clinic
Tulsa, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
McCoy SJ, Beal JM, Payton ME, Stewart AL, DeMers AM, Watson GH. Postpartum thyroid measures and depressive symptomology: a pilot study. J Am Osteopath Assoc. 2008 Sep;108(9):503-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9899015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.